Patient-Reported Outcome Measures in Oncology Drugs Approved by the European Medicines Agency, 2017-2021

This cross-sectional study investigates the use of patient-reported outcome measures in new marketing authorizations for oncology drugs approved by the European Medicines Agency (EMA) between 2017 and 2021.

Detalles Bibliográficos
Autores principales: Ciani, Oriana, Meregaglia, Michela, De Lorenzo, Francesco, Perrone, Francesco, Pinto, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857398/
https://www.ncbi.nlm.nih.gov/pubmed/36656587
http://dx.doi.org/10.1001/jamanetworkopen.2022.51564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857398/
https://www.ncbi.nlm.nih.gov/pubmed/36656587
http://dx.doi.org/10.1001/jamanetworkopen.2022.51564

Ejemplares similares